John T. Wilson

Encapsulating Synthetic STING Agonist, MSA-2, in Endosomolytic Polymersomes for Cancer Immunotherapy

Utilization of STING agonist MSA-2 encapsulated nanocarriers to enhance the immune system’s ability to eliminate cancer cells.
In Vitro Analysis of Synergy between Adjuvants MPLA, CpG, and cGAMP for Treatment of Cancer

Synergistic application of adjuvants was used to analyze interferon and NF-κB immunological responses in mouse macrophages for the treatment of cancer.